Follow the NervGen Pharma Corp. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares trade on CA CA, under the oversight of SEDI. Operating in the Health Care sector, NervGen Pharma Corp. has recorded 9 reports. Market capitalisation: €379.7m. The latest transaction was filed on 8 July 2026 (46 - Compensation for services). Among the most active insiders: Rogers, Adam. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1,146,108 shares@ CA$3.99100.0% of flowOptionsTSXSEDI:4725769
9 of 9 declarations
About NervGen Pharma Corp.
NervGen Pharma Corp. is a biopharmaceutical company focused on developing treatments for neurological diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.